Nachhaltig leben. lernen. forschen

Medizinische Universität Graz

Publikationen von: Khalil Michael

2018

Originalarbeiten (Zeitschrift)

Pinter, D; Gattringer, T; Enzinger, C; Seifert-Held, T; Kneihsl, M; Fandler, S; Pichler, A; Barro, C; Eppinger, S; Pirpamer, L; Bachmaier, G; Ropele, S; Wardlaw, JM; Kuhle, J; Khalil, M; Fazekas, F
(2018): Longitudinal MRI dynamics of recent small subcortical infarcts and possible predictors. J Cereb Blood Flow Metab. 2018; 94:271678X18775215-271678X18775215
[Fulltext][PubMed]



2017

Originalarbeiten (Zeitschrift)

Borsodi, F; Culea, V; Langkammer, C; Khalil, M; Pirpamer, L; Quasthoff, S; Enzinger, C; Schmidt, R; Fazekas, F; Ropele, S
(2017): Multimodal assessment of white matter tracts in amyotrophic lateral sclerosis. PLoS One. 2017; 12(6): e0178371-e0178371.
[Fulltext][PubMed]

Engelborghs, S; Niemantsverdriet, E; Struyfs, H; Blennow, K; Brouns, R; Comabella, M; Dujmovic, I; van der Flier, W; Frölich, L; Galimberti, D; Gnanapavan, S; Hemmer, B; Hoff, E; Hort, J; Iacobaeus, E; Ingelsson, M; Jan de Jong, F; Jonsson, M; Khalil, M; Kuhle, J; Lleó, A; de Mendonça, A; Molinuevo, JL; Nagels, G; Paquet, C; Parnetti, L; Roks, G; Rosa-Neto, P; Scheltens, P; Skårsgard, C; Stomrud, E; Tumani, H; Visser, PJ; Wallin, A; Winblad, B; Zetterberg, H; Duits, F; Teunissen, CE
(2017): Consensus guidelines for lumbar puncture in patients with neurological diseases. Alzheimers Dement (Amst). 2017; 8: 111-126.
[Fulltext][PubMed]

Gattringer, T; Pinter, D; Enzinger, C; Seifert-Held, T; Kneihsl, M; Fandler, S; Pichler, A; Barro, C; Gröbke, S; Voortman, M; Pirpamer, L; Hofer, E; Ropele, S; Schmidt, R; Kuhle, J; Fazekas, F; Khalil, M
(2017): Serum neurofilament light is sensitive to active cerebral small vessel disease. Neurology. 2017; 89(20):2108-2114
[Fulltext][PubMed]

Moser, AM; Spindelboeck, W; Strohmaier, H; Enzinger, C; Gattringer, T; Fuchs, S; Fazekas, F; Gorkiewicz, G; Wurm, P; Högenauer, C; Khalil, M
(2017): Mucosal biopsy shows immunologic changes of the colon in patients with early MS. Neurol Neuroimmunol Neuroinflamm. 2017; 4(4): e362-e362.
[Fulltext][PubMed]

Pichler, A; Khalil, M; Langkammer, C; Pinter, D; Ropele, S; Fuchs, S; Bachmaier, G; Enzinger, C; Fazekas, F
(2017): The impact of vascular risk factors on brain volume and lesion load in patients with early multiple sclerosis. Mult Scler. 2017; 1352458517736149-1352458517736149
[Fulltext][PubMed]

Voortman, MM; Pekar, T; Bachmayer, D; Archelos, JJ; Stojakovic, T; Scharnagl, H; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Seifert-Held, T; Khalil, M
(2017): Serum netrin-1 in relation to gadolinium-enhanced magnetic resonance imaging in early multiple sclerosis. Mult Scler J Exp Transl Clin. 2017; 3(3): 2055217317727294-2055217317727294.
[Fulltext][PubMed]

Voortman, MM; Stojakovic, T; Pirpamer, L; Jehna, M; Langkammer, C; Scharnagl, H; Reindl, M; Ropele, S; Seifert-Held, T; Archelos, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M
(2017): Prognostic value of free light chains lambda and kappa in early multiple sclerosis. Mult Scler. 2017; 23(11):1496-1505
[Fulltext][PubMed]

Gattringer, T; Khalil, M; Langkammer, C; Pinter, D; Ropele, S; Fazekas, F; Enzinger, C
(2017): Comment on the letter to the editor entitled "Brain iron deposition in patients with white matter hyperintensities of presumed vascular origin" by D. Zhou. Neurobiol Aging. 2017; 53(5):198-198
[Fulltext][PubMed]

Fissolo, N; Issazadeh-Navikas, S; Dujmovic, I; Voortman, MM; Khalil, M; Montalban, X; Comabella, M.
(2017): Serpina3n: potential biomarker in patients with progressive multiple sclerosis. Multiple Sclerosis Journal. 2017; 23(S3):219-219.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting ; OCT 25-28, 2017; Paris, FRANCE.
[Fulltext]

Gattringer, T; Pinter, D; Enzinger, C; Kneihsl, M; Fandler, S; Pichler, A; Barro, C; Grobke, S; Voortman, M; Seifert-Held, T; Pirpamer, L; Hofer, E; Ropele, S; Schmidt, R; Kuhle, J; Fazekas, F; Khalil, M
(2017): Serum neurofilament light chain protein: A promising biomarker for lacunar stroke and cerebral small vessel disease. EUR J NEUROL. 2017; 24: 462-462.-3rd Congress of the European Academy of Neurology (EAN); JUN 24-27, 2017; Amsterdam, THE NETHERLANDS.


Hallwirth, F; Moser, D; Voortman, MM; Greiner, P; Fuchs, S; Enzinger, C; Bachmaier, G; Gruber, H-J; Fazekas; Khalil, M
(2017): Serum nitric oxide is increased in untreated multiple sclerosis patients. Mult Scler J. 2017; 23(S3):586-587.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting ; OCT 25-28, 2017; Paris, FRANCE.


Leurs CE; Twaalfhoven, HAM; Witte, BI; Van Pesch, V; Dujmovic, I; Drulovic, J; Castellazzi, M; Bellini, T; Pugliatti, M; Kuhle, J; Villar, LM; Alvarez Cermeño, JC; Alvarez-Lafuente, R; Hegen, H; Deisenhammer, F; Thouvenot, E; Comabella, M; Montalban, X; Vécsei, L; Rajda, C; Galimberti, D; Altintas, A; Rejdak, K; Frederiksen, JL; Pihl-Jensen, G; Jensen, PE; Khalil, M; Voortman, MM; Fazekas, F; Saiz, A; La Puma, D; Vercammen, MJ; VanopdenBosch, L; Uitdehaag, BMJ; Killestein, J; Teunissen, C.
(2017): Kappa free light chains: an automated alternative to oligoclonal bands for CIS and MS diagnosis? Multiple Sclerosis Journal. 2017; 23(S3):591-592.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting ; OCT 25-28, 2017; Paris, FRANCE.
[Fulltext]

Pinter, D; Beckmann, C; Fazekas, F; Khalil, M; Pichler, A; Ropele, S; Fuchs, S; Enzinger, C
(2017): Morphologic MRI phenotyping of multiple sclerosis associates with altered brain function MULT SCLER J. 2017; 23: 539-540.


Pinter, D; Fazekas, F; Damulina, A; Pirpamer, L; Pichler, A; Khalil, M; Ropele, S; Fuchs, S; Enzinger, C
(2017): Evolution of cognitive function in MS and its relationship to physical disability and MRI metrics MULT SCLER J. 2017; 23: 285-286.


Pinter, D; Pirpamer, L; Damulina, A; Fazekas, F; Pichler, A; Khalil, M; Fuchs, S; Enzinger, C
(2017): Long-term course of cognitive function and disability in patients with MS MULT SCLER J. 2017; 23(8): NP1-NP1.


Voortman, M; Pekar, T; Bachmayer, D; Archelos-Garcia, JJ; Stojakovic, T; Scharnagl, H; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Seifert-Held, T; Khalil, M
(2017): The role of serum netrin-1 in early multiple sclerosis. EUR J NEUROL. Eur J Neurol 2017; 24 (Suppl 1). 2017; 24: 313-313.-3rd Congress of the European Academy of Neurology (EAN); JUN 24-27, 2017; Amsterdam, THE NETHERLANDS.
[Fulltext]

Voortman, MM; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos, JJ; Fazekas, F; Marsche, G; Khalil, M
(2017): Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early multiple sclerosis. Multiple Sclerosis Journal. 2017; 23(S3):303-304.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting; OCT 25-28, 2017; Paris, FRANCE.
[Fulltext]



2016

Originalarbeiten (Zeitschrift)

Gattringer, T; Khalil, M; Langkammer, C; Jehna, M; Pichler, A; Pinter, D; Kneihsl, M; Petrovic, K; Ropele, S; Fazekas, F; Enzinger, C
(2016): No evidence for increased brain iron deposition in patients with ischemic white matter disease. Neurobiol Aging. 2016; 45(16):61-63
[Fulltext][PubMed]

Hegen, H; Adrianto, I; Lessard, CJ; Millonig, A; Bertolotto, A; Comabella, M; Giovannoni, G; Guger, M; Hoelzl, M; Khalil, M; Fazekas, F; Killestein, J; Lindberg, RL; Malucchi, S; Mehling, M; Montalban, X; Rudzki, D; Schautzer, F; Sellebjerg, F; Sorensen, PS; Deisenhammer, F; Steinman, L; Axtell, RC
(2016): Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients. Neurol Neuroimmunol Neuroinflamm. 2016; 3(2):e202-e202
[Fulltext][PubMed]

Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Bachmaier, G; Pichler, A; Archelos, JJ; Fuchs, S; Seifert-Held, T; Fazekas, F
(2016): Cerebrospinal fluid lipocalin 2 in patients with clinically isolated syndromes and early multiple sclerosis. Mult Scler. 2016; 22(12):1560-1568
[Fulltext][PubMed]

Kneihsl, M; Enzinger, C; Wünsch, G; Khalil, M; Culea, V; Urbanic-Purkart, T; Payer, F; Niederkorn, K; Fazekas, F; Gattringer, T
(2016): Poor short-term outcome in patients with ischaemic stroke and active cancer. J Neurol. 2016; 263(1):150-156
[Fulltext][PubMed]

Pichler, A; Khalil, M; Langkammer, C; Pinter, D; Bachmaier, G; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F
(2016): Combined analysis of global and compartmental brain volume changes in early multiple sclerosis in clinical practice. Mult Scler. 2016; 22(3):340-346
[Fulltext][PubMed]

Tuller, F; Holzer, H; Schanda, K; Aboulenein-Djamshidian, F; Höftberger, R; Khalil, M; Seifert-Held, T; Leutmezer, F; Berger, T; Reindl, M
(2016): Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disorders. J Neuroinflammation. 2016; 13(1):176-176
[Fulltext][PubMed]

Khalil, M; Salzer, J
(2016): CSF neurofilament light: A universal risk biomarker in multiple sclerosis? Neurology. 2016; 87(11):1068-1069
[Fulltext][PubMed]

Pichler, A; Khalil, M; Langkammer, C; Pinter, D; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F
(2016): The impact of cardiovascular comorbidities on the temporal evolution of brain volume and lesion load in early multiple sclerosis. MULT SCLER J. 2016; 22: 70-70.


Pinter, D; Khalil, M; Greiner, P; Moser, D; Koini, M; Pirker, E; Pichler, A; Bachmaier, G; Ropele, S; Fuchs, S; Fazekas, F; Enzinger, C
(2016): The relationship between resting-state connectivity alterations and the extent of focal white matter lesion changes in multiple sclerosis MULT SCLER J. 2016; 22: 759-759.


Pinter, D; Khalil, M; Greiner, P; Moser, D; Pirker, E; Pichler, A; Bachmaier, G; Ropele, S; Fuchs, S; Fazekas, F; Enzinger, C
(2016): Lesion filling more strongly affects estimation of grey than white matter volumes in a large patient sample depending on hyperintense lesion load MULT SCLER J. 2016; 22: 512-512.


Spindelboeck, W; Moser, AM; Strohmaier, H; Enzinger, C; Gattringer, T; Fuchs, S; Fazekas, F; Gorkiewicz, G; Wurm, P; Hogenauer, C; Khalil, M
(2016): Mucosal biopsy reveals immunologic changes of the colon in patients with early multiple sclerosis MULT SCLER J. 2016; 22: 179-179.


Voortman, M; Bachmayer, D; Seifert-Held, T; Archelos, JJ; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Khalil, M
(2016): No association of serum Netrin-1 with MRI based evidence of disease activity in early multiple sclerosis. MULT SCLER J. 2016; 22: 274-274.-32nd Congress of the European Committee for Treatment and Research in Multiple-Sclerosis (ECTRIMS); SEP 14-17, 2016; London, UNITED KINGDOM.




2015

Originalarbeiten (Zeitschrift)

Cantó, E; Tintoré, M; Villar, LM; Costa, C; Nurtdinov, R; Álvarez-Cermeño, JC; Arrambide, G; Reverter, F; Deisenhammer, F; Hegen, H; Khademi, M; Olsson, T; Tumani, H; Rodríguez-Martín, E; Piehl, F; Bartos, A; Zimova, D; Kotoucova, J; Kuhle, J; Kappos, L; García-Merino, JA; Sánchez, AJ; Saiz, A; Blanco, Y; Hintzen, R; Jafari, N; Brassat, D; Lauda, F; Roesler, R; Rejdak, K; Papuc, E; de Andrés, C; Rauch, S; Khalil, M; Enzinger, C; Galimberti, D; Scarpini, E; Teunissen, C; Sánchez, A; Rovira, A; Montalban, X; Comabella, M
(2015): Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes. Brain. 2015; 138(Pt 4): 918-931.
[Fulltext][PubMed]

Gattringer, T; Enzinger, C; Fischer, R; Seyfang, L; Niederkorn, K; Khalil, M; Ferrari, J; Lang, W; Brainin, M; Willeit, J; Fazekas, F
(2015): IV thrombolysis in patients with ischemic stroke and alcohol abuse. Neurology. 2015; 85(18): 1592-1597.
[Fulltext][PubMed]

Jehna, M; Pirpamer, L; Khalil, M; Fuchs, S; Ropele, S; Langkammer, C; Pichler, A; Stulnig, F; Deutschmann, H; Fazekas, F; Enzinger, C
(2015): Periventricular lesions correlate with cortical thinning in multiple sclerosis. Ann Neurol. 2015; 78(4): 530-539.
[Fulltext][PubMed]

Khalil, M; Langkammer, C; Pichler, A; Pinter, D; Gattringer, T; Bachmaier, G; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F
(2015): Dynamics of brain iron levels in multiple sclerosis: A longitudinal 3T MRI study. Neurology. 2015; 84(24): 2396-2402.
[Fulltext][PubMed]

Kuhle, J; Disanto, G; Dobson, R; Adiutori, R; Bianchi, L; Topping, J; Bestwick, JP; Meier, UC; Marta, M; Costa, GD; Runia, T; Evdoshenko, E; Lazareva, N; Thouvenot, E; Iaffaldano, P; Direnzo, V; Khademi, M; Piehl, F; Comabella, M; Sombekke, M; Killestein, J; Hegen, H; Rauch, S; D'Alfonso, S; Alvarez-Cermeño, JC; Kleinová, P; Horáková, D; Roesler, R; Lauda, F; Llufriu, S; Avsar, T; Uygunoglu, U; Altintas, A; Saip, S; Menge, T; Rajda, C; Bergamaschi, R; Moll, N; Khalil, M; Marignier, R; Dujmovic, I; Larsson, H; Malmestrom, C; Scarpini, E; Fenoglio, C; Wergeland, S; Laroni, A; Annibali, V; Romano, S; Martínez, AD; Carra, A; Salvetti, M; Uccelli, A; Torkildsen, Ø; Myhr, KM; Galimberti, D; Rejdak, K; Lycke, J; Frederiksen, JL; Drulovic, J; Confavreux, C; Brassat, D; Enzinger, C; Fuchs, S; Bosca, I; Pelletier, J; Picard, C; Colombo, E; Franciotta, D; Derfuss, T; Lindberg, R; Yaldizli, Ö; Vécsei, L; Kieseier, BC; Hartung, HP; Villoslada, P; Siva, A; Saiz, A; Tumani, H; Havrdová, E; Villar, LM; Leone, M; Barizzone, N; Deisenhammer, F; Teunissen, C; Montalban, X; Tintoré, M; Olsson, T; Trojano, M; Lehmann, S; Castelnovo, G; Lapin, S; Hintzen, R; Kappos, L; Furlan, R; Martinelli, V; Comi, G; Ramagopalan, SV; Giovannoni, G
(2015): Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study. Mult Scler. 2015; 21(8): 1013-1024.
[Fulltext][PubMed]

Pinter, D; Khalil, M; Pichler, A; Langkammer, C; Ropele, S; Marschik, PB; Fuchs, S; Fazekas, F; Enzinger, C
(2015): Predictive value of different conventional and non-conventional MRI-parameters for specific domains of cognitive function in multiple sclerosis. Neuroimage Clin. 2015; 7(4):715-720
[Fulltext][PubMed]

Gattringer, T; Kneihsl, M; Enzinger, C; Wunsch, G; Khalil, M; Urbanic-Purkart, T; Payer, F; Niederkorn, K; Fazekas, F
(2015): Poor short-term outcome in patients with ischemic stroke and active cancer EUR J NEUROL. 2015; 22: 228-228.-1st Congress of the European-Academy-of-Neurology; JUN, 2015; Berlin, GERMANY.


Jehna, M; Pirpamer, L; Khalil, M; Fuchs, S; Ropele, S; Langkammer, C; Pichler, A; Stulnig, F; Deutschmann, H; Fazekas, F; Enzinger, C
(2015): Periventricular lesion burden in multiple sclerosis correlates with cortical thinning MULT SCLER J. 2015; 21: 180-181.-31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 07-10, 2015; Barcelona, SPAIN.
[Fulltext]

Jehna, M; Pirpamer, L; Khalil, M; Stulnig, F; Fuchs, S; Ropele, S; Langkammer, C; Pichler, A; Deutschmann, H; Fazekas, F; Enzinger, C
(2015): Periventricular lesion burden in multiple sclerosis correlates with cortical thinning EUR J NEUROL. 2015; 22: 155-155.-1st Congress of the European-Academy-of-Neurology; JUN, 2015; Berlin, GERMANY.
[Fulltext]

Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Archelos-Garcia, JJ; Fuchs, S; Seifert-Held, T; Fazekas, F
(2015): Cerebrospinal fluid lipocalin-2 levels are reduced in multiple sclerosis and correlate with putaminal iron accumulation EUR J NEUROL. 2015; 22: 87-87.-1st Congress of the European-Academy-of-Neurology; JUN, 2015; Berlin, GERMANY.


Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Bachmaier, G; Archelos, JJ; Fuchs, S; Seifert-Held, T; Fazekas, F
(2015): Impact of cerebrospinal fluid lipocalin-2 on brain iron accumulation and clinical progression in multiple sclerosis MULT SCLER J. 2015; 21: 632-632.-31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 07-10, 2015; Barcelona, SPAIN.


Voortman, M; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos-Garcia, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M
(2015): Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning. EUR J NEUROL. 2015; 22: 398-398.-1st Congress of the European Academy of Neurology (EAN); JUN, 2015; Berlin, GERMANY.


Voortman, MM; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M
(2015): Increased cerebrospinal fluid immunoglobulin free light chain levels in relation to lesion load and cortical thinning of multiple sclerosis patients MULT SCLER J. 2015; 21: 630-630.-31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 07-10, 2015; Barcelona, SPAIN.


Walleczek, NK; Rauschka, H; Bsteh, G; Birkl, CB; Khalil, M; Fuchs, S; Enzinger, C; Fazekas, F; Eggers, C; Leutmezer, F; Salhofer-Polanyi, S; Baumgartner, A; Blechinger, S; Koppi, S; Sellner, J; Kraus, J; Assar, H; Gugger, M; Ehling, R; Moser, H; Raber, B; Liendl, H; Parigger, S; Mayr, M; Hiller, MS; Meister, B; Morgenstern, G; Spiess, HK; Kempf, I; Cisar, A; Bachler, H; Lehninger, R; Berger, T; Kristoferitsch, W; Aboulenein-Djamshidian, F
(2015): Month-of-birth-effect in multiple sclerosis in Austria MULT SCLER J. 2015; 21: 102-103.-31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 07-10, 2015; Barcelona, SPAIN.




2014

Originalarbeiten (Zeitschrift)

Gattringer, T; Enzinger, C; Khalil, M; Schwingenschuh, P; Pichler, A; Moser, A; Graninger, W; Ernst, C; Haybaeck, J; Fazekas, F
(2014): Unusual deterioration in a patient with multiple sclerosis on natalizumab therapy. Neurol Neuroimmunol Neuroinflamm. 2014; 1(1):e1-e1
[Fulltext][PubMed]

Gnanapavan, S; Hegen, H; Khalil, M; Hemmer, B; Franciotta, D; Hughes, S; Hintzen, R; Jeromin, A; Havrdova, E; Tumani, H; Bertolotto, A; Comabella, M; Frederiksen, J; Álvarez-Cermeño, JC; Villar, L; Galimberti, D; Myhr, KM; Dujmovic, I; Fazekas, F; Ionete, C; Menge, T; Kuhle, J; Keir, G; Deisenhammer, F; Teunissen, C; Giovannoni, G
(2014): Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders. Neurology. 2014; 83(13):1210-1216
[Fulltext][PubMed]

Hegen, H; Millonig, A; Bertolotto, A; Comabella, M; Giovanonni, G; Guger, M; Hoelzl, M; Khalil, M; Killestein, J; Lindberg, R; Malucchi, S; Mehling, M; Montalban, X; Polman, CH; Rudzki, D; Schautzer, F; Sellebjerg, F; Sørensen, PS; Deisenhammer, F
(2014): Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development. Mult Scler. 2014; 20(5):577-587
[Fulltext][PubMed]

Khalil, M; Riedlbauer, B; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Culea, V; Petzold, A; Teunissen, C; Archelos, JJ; Fuchs, S; Fazekas, F
(2014): Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis. Mult Scler. 2014; 20(12):1569-1577
[Fulltext][PubMed]

Pinter, D; Sumowski, J; DeLuca, J; Fazekas, F; Pichler, A; Khalil, M; Langkammer, C; Fuchs, S; Enzinger, C
(2014): Higher education moderates the effect of T2 lesion load and third ventricle width on cognition in multiple sclerosis. PLoS One. 2014; 9(1):e87567-e87567
[Fulltext][PubMed]

Ropele, S; Kilsdonk, ID; Wattjes, MP; Langkammer, C; de Graaf, WL; Frederiksen, JL; Larsson, HB; Yiannakas, M; Wheeler-Kingshott, CA; Enzinger, C; Khalil, M; Rocca, MA; Sprenger, T; Amann, M; Kappos, L; Filippi, M; Rovira, A; Ciccarelli, O; Barkhof, F; Fazekas, F
(2014): Determinants of iron accumulation in deep grey matter of multiple sclerosis patients. Mult Scler. 2014; 20(13):1692-1698
[Fulltext][PubMed]

Enzinger, C (presented on behalf of Khalil M); Khalil, M; Langkammer, C; Pichler, A; Pinter, D; Mader, A; Bachmaier, G; Ropele, S; Fuchs, S; Fazekas, F;
(2014): Dynamics of brain iron accumulation differ between clinically isolated syndrome and multiple sclerosis: a longitudinal 3T MRI study. EUR J NEUROLOGY. EUROPEAN JOURNAL OF NEUROLOGY21: 58-58. HOBOKEN: WILEY-BLACKWELL; ( Presented at: Joint Congress of European Neurology, Istanbul, TURKEY, MAY 31-JUN 03, 2014)


Hegen, H; Axtell, R; Hu, Y; Millonig, A; Bertolotto, A; Comabella, M; Giovanonni, G; Guger, M; Hoelzl, M; Khalil, M; Killestein, J; Lindberg, R; Malucchi, S; Mehling, M; Montalban, X; Rudzki, D; Schautzer, F; Sellebjerg, F; Sorensen, PS; Steinman, L; Deisenhammer, F
(2014): Serum biomarkers predict IFNb treatment response in patients with multiple sclerosis J NEUROL. 2014; 261: S43-S43.


Hegen, H; Axtell, R; Hu, Y; Millonig, A; Bertolotto, A; Comabella, M; Giovanonni, G; Guger, M; Hoelzl, M; Khalil, M; Killestein, J; Lindberg, R; Malucchi, S; Mehling, M; Montalban, X; Rudzki, D; Schautzer, F; Sellebjerg, F; Sorensen, PS; Steinman, L; Deisenhammer, F;
(2014): Serum biomarkers predict IFNb treatment response in patients with multiple sclerosis. EUR J NEUROLOGY. 2014; 21: 57-57.-Joint Congress of European Neurology; MAY 31-JUN 03, 2014; Istanbul, TURKEY.


Khalil, M; Langkammer, C; Pichler, A; Pinter, D; Mader, A; Bachmaier, G; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F
(2014): Dynamics of brain iron accumulation differ between clinically isolated syndrome and multiple sclerosis: a longitudinal 3T MRI study J NEUROL. 2014; 261: S43-S43.-Joint Congress of European Neurology; MAY 31-JUN 03, 2014; Istanbul, TURKEY.


Pichler, A; Khalil, M; Langkammer, C; Mader, A; Bachmaier, G; Ropele, S; Fuchs, S; Pinter, D; Enzinger, C; Fazekas, F
(2014): Longitudinal changes of global and compartmental brain atrophy in patients with clinically isolated syndrome and clinically definite multiple sclerosis using 3-Tesla magnetic resonance imaging J NEUROL. 2014; 261: S44-S44.-Joint Congress of European Neurology; MAY 31-JUN 03, 2014; Istanbul, TURKEY.


Pichler, A; Khalil, M; Langkammer, C; Mader, A; Bachmaier, G; Ropele, S; Fuchs, S; Pinter, D; Enzinger, C; Fazekas, F;
(2014): Longitudinal changes of global and compartmental brain atrophy in patients with clinically isolated syndrome and clinically definite multiple sclerosis using 3-Tesla magnetic resonance imaging. EUR J NEUROLOGY. EUROPEAN JOURNAL OF NEUROLOGY21: 59-59. HOBOKEN: WILEY-BLACKWELL; ( Presented at: Joint Congress of European Neurology, Istanbul, TURKEY, MAY 31-JUN 03, 2014)




2013

Originalarbeiten (Zeitschrift)

Fazekas, C; Khalil, M; Enzinger, C; Matzer, F; Fuchs, S; Fazekas, F
(2013): No impact of adult attachment and temperament on clinical variability in patients with clinically isolated syndrome and early multiple sclerosis. Clin Neurol Neurosurg. 2013; 115(3):293-297
[Fulltext][PubMed]

Jehna, M; Langkammer, C; Khalil, M; Fuchs, S; Reishofer, G; Fazekas, F; Ebner, F; Enzinger, C
(2013): An exploratory study on the spatial relationship between regional cortical volume changes and white matter integrity in multiple sclerosis. Brain Connect. 2013; 3(3):255-264
[Fulltext][PubMed]

Khalil, M; Ebner, F; Fazekas, F; Enzinger, C
(2013): Idiopathic hypertrophic cranial pachymeningitis: a rare but treatable cause of headache and facial pain. J Neurol Neurosurg Psychiatry. 2013; 84(3):354-355
[Fulltext][PubMed]

Khalil, M; Enzinger, C; Langkammer, C; Ropele, S; Mader, A; Trentini, A; Vane, ML; Wallner-Blazek, M; Bachmaier, G; Archelos, JJ; Koel-Simmelink, MJ; Blankenstein, MA; Fuchs, S; Fazekas, F; Teunissen, CE
(2013): CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome. Mult Scler. 2013; 19(4):436-442
[Fulltext][PubMed]

Langkammer, C; Liu, T; Khalil, M; Enzinger, C; Jehna, M; Fuchs, S; Fazekas, F; Wang, Y; Ropele, S
(2013): Quantitative susceptibility mapping in multiple sclerosis. Radiology. 2013; 267(2):551-559
[Fulltext][PubMed]

Pichler, A; Enzinger, C; Fuchs, S; Plecko-Startinig, B; Gruber-Sedlmayr, U; Linortner, P; Langkammer, C; Khalil, M; Ebner, F; Ropele, S; Fazekas, F
(2013): Differences and similarities in the evolution of morphologic brain abnormalities between paediatric and adult-onset multiple sclerosis. Mult Scler. 2013; 19(2):167-172
[Fulltext][PubMed]

Teunissen, C; Menge, T; Altintas, A; Álvarez-Cermeño, JC; Bertolotto, A; Berven, FS; Brundin, L; Comabella, M; Degn, M; Deisenhammer, F; Fazekas, F; Franciotta, D; Frederiksen, JL; Galimberti, D; Gnanapavan, S; Hegen, H; Hemmer, B; Hintzen, R; Hughes, S; Iacobaeus, E; Kroksveen, AC; Kuhle, J; Richert, J; Tumani, H; Villar, LM; Drulovic, J; Dujmovic, I; Khalil, M; Bartos, A
(2013): Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis. Mult Scler. 2013; 19(13):1802-1809
[Fulltext][PubMed]

Canto, E; Tintore, M; Costa, C; Arrambide, G; Villar, LM; Alvarez-Cermeno, JC; Deisenhammer, F; Hegen, H; Khademi, M; Olsson, T; Piehl, F; Bartos, A; Simova, D; Kotoucova, J; Kuhle, J; Kappos, L; Garcia-Merino, JA; Saiz, A; Blanco, Y; Hintzen, R; Jafari, N; Brassat, D; Tumani, H; Lauda, F; Roesler, R; Rejdak, K; Papuc, E; de Andres, C; Khalil, M; Galimberti, D; Scarpini, E; Montalban, X; Comabella, M
(2013): Validation of cerebrospinal fluid chitinase 3-like 1 as a prognostic biomarker of conversion to multiple sclerosis and disease severity in patients with clinically isolated syndromes MULT SCLER J. 2013; 19(11): 44-45.


Hegen, H; Millonig, A; Bertolotto, A; Comabella, M; Giovanonni, G; Guger, M; Hoelzl, M; Khalil, M; Killestein, J; Lindberg, R; Malucchi, S; Mehling, M; Montalban, X; Polman, C; Rudzki, D; Schautzer, F; Sellebjerg, F; Sorensen, PS; Deisenhammer, F
(2013): Early detection of neutralizing antibodies to interferon beta in multiple sclerosis patients MULT SCLER J. 2013; 19(11): 294-295.


Khalil, M; Riedlbauer, B; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Culea, V; Petzold, A; Teunissen, C; Archelos, JJ; Fuchs, S; Fazekas, F
(2013): Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis MULT SCLER J. 2013; 19(11): 545-545.


Kuhle, J; Dobson, R; Bestwick, JP; Topping, J; Dalla Costa, G; Khademi, M; Sombekke, M; Killestein, J; Evdoshenko, E; Lazareva, N; Runia, T; Zbornikova, P; Horakova, D; D'Alfonso, S; Thouvenot, E; Moll, N; Hegen, H; Rauch, S; Khalil, M; Fuchs, S; Lindberg, RLP; Derfuss, T; Llufriu, S; Franciotta, D; Roesler, R; Lauda, F; Rajda, C; Drulovic, J; Menge, T; Kieseier, BC; Avsar, T; Marignier, R; Malmestrom, C; Myhr, KM; Wergeland, S; Annibali, V; Romano, S; Carra, A; Laroni, A; Frederiksen, JL; Larsson, HB; Uccelli, A; Martinez, AD; Salvetti, M; Torkildsen, O; Lycke, J; Confavreux, C; Rejdak, K; Bosca, I; Brassat, D; Scarpini, E; Fenoglio, C; Galimberti, D; Siva, A; Hartung, HP; Dujmovic, I; Vecsei, L; Tumani, H; Bergamaschi, R; Colombo, E; Villoslada, P; Saiz, A; Enzinger, C; Kappos, L; Deisenhammer, F; Alvarez-Cermeno, JC; Villar, L; Pelletier, J; Lehmann, S; Castelnovo, G; Barizzone, N; Leone, M; Havrdova, E; Trojano, M; Iaffaldano, P; Direnzo, V; Comabella, M; Tintore, M; Montalban, X; Hintzen, R; Lapin, S; Teunissen, C; Piehl, F; Olsson, T; Furlan, R; Martinelli, V; Comi, G; Ramagopalan, S; Giovannoni, G
(2013): Multivariate clinically isolated syndrome (CIS) risk factor study: towards individual prognosis and treatment indication in CIS MULT SCLER J. 2013; 19(11): 33-34.


Pinter, D; Sumowski, J; DeLuca, J; Fazekas, F; Pichler, A; Khalil, M; Langkammer, C; Fuchs, S; Enzinger, C
(2013): Educational attainment moderates the effect of T2 lesion load and thalamic atrophy on cognition in multiple sclerosis MULT SCLER J. 2013; 19(11): 437-438.




2012

Originalarbeiten (Zeitschrift)

Schmied, MC; Zehetmayer, S; Reindl, M; Ehling, R; Bajer-Kornek, B; Leutmezer, F; Zebenholzer, K; Hotzy, C; Lichtner, P; Meitinger, T; Wichmann, HE; Illig, T; Gieger, C; Huber, K; Khalil, M; Fuchs, S; Schmidt, H; Auff, E; Kristoferitsch, W; Fazekas, F; Berger, T; Vass, K; Zimprich, A
(2012): Replication study of multiple sclerosis (MS) susceptibility alleles and correlation of DNA-variants with disease features in a cohort of Austrian MS patients. Neurogenetics. 2012; 13(2):181-187
[Fulltext][PubMed]

Teunissen, CE; Khalil, M
(2012): Neurofilaments as biomarkers in multiple sclerosis. Mult Scler. 2012; 18(5):552-556
[Fulltext][PubMed]



2011

Originalarbeiten (Zeitschrift)

Enzinger, C; Fuchs, S; Pichler, A; Wallner-Blazek, M; Khalil, M; Langkammer, C; Ropele, S; Fazekas, F
(2011): Predicting the severity of relapsing-remitting MS: The contribution of cross-sectional and short-term follow-up MRI data. Mult Scler. 2011; 17(6): 695-701.
[Fulltext][PubMed]

Jehna, M; Langkammer, C; Wallner-Blazek, M; Neuper, C; Loitfelder, M; Ropele, S; Fuchs, S; Khalil, M; Pluta-Fuerst, A; Fazekas, F; Enzinger, C
(2011): Cognitively preserved MS patients demonstrate functional differences in processing neutral and emotional faces. Brain Imaging Behav. 2011; 5(4): 241-251.
[Fulltext][PubMed]

Khalil, M; Enzinger, C; Langkammer, C; Petrovic, K; Loitfelder, M; Tscherner, M; Jehna, M; Bachmaier, G; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F
(2011): Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome. Mult Scler. 2011; 17(2): 173-180.
[Fulltext][PubMed]

Khalil, M; Langkammer, C; Ropele, S; Petrovic, K; Wallner-Blazek, M; Loitfelder, M; Jehna, M; Bachmaier, G; Schmidt, R; Enzinger, C; Fuchs, S; Fazekas, F
(2011): Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study. Neurology. 2011; 77(18): 1691-1697.
[Fulltext][PubMed]

Khalil, M; Teunissen, C; Langkammer, C
(2011): Iron and neurodegeneration in multiple sclerosis. Mult Scler Int. 2011; 2011(4):606807-606807
[Fulltext][PubMed]

Kincses, ZT; Ropele, S; Jenkinson, M; Khalil, M; Petrovic, K; Loitfelder, M; Langkammer, C; Aspeck, E; Wallner-Blazek, M; Fuchs, S; Jehna, M; Schmidt, R; Vécsei, L; Fazekas, F; Enzinger, C
(2011): Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosis. Mult Scler. 2011; 17(6): 681-689.
[Fulltext][PubMed]

Loitfelder, M; Fazekas, F; Petrovic, K; Fuchs, S; Ropele, S; Wallner-Blazek, M; Jehna, M; Aspeck, E; Khalil, M; Schmidt, R; Neuper, C; Enzinger, C
(2011): Reorganization in cognitive networks with progression of multiple sclerosis: insights from fMRI. Neurology. 2011; 76(6): 526-533.
[Fulltext][PubMed]

Ropele, S; de Graaf, W; Khalil, M; Wattjes, MP; Langkammer, C; Rocca, MA; Rovira, A; Palace, J; Barkhof, F; Filippi, M; Fazekas, F
(2011): MRI assessment of iron deposition in multiple sclerosis. J Magn Reson Imaging. 2011; 34(1): 13-21.
[Fulltext][PubMed]

Rovaris, M; Rocca, MA; Barkhof, F; Calabrese, M; De Stefano, N; Khalil, M; Fazekas, F; Fisniku, L; Gallo, P; Miller, DH; Montalban, X; Polman, C; Rovira, A; Sombekke, MH; Sormani, MP; Stromillo, ML; Filippi, M
(2011): Relationship between brain MRI lesion load and short-term disease evolution in non-disabling MS: a large-scale, multicentre study. Mult Scler. 2011; 17(3): 319-326.
[Fulltext][PubMed]

Teunissen, C; Koel-Simmelink, M; Pham, T; Knol, J; Khalil, M; Trentini, A; Killestein, J; Nielsen, J; Vrenken, H; Popescu, V; Dijkstra, C; Jimenez, C
(2011): Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry. Mult Scler. 2011; 17(7):838-850
[Fulltext][PubMed]

Jehna, M; Langkammer, C; Wallner-Blazek, M; Neuper, C; Loitfelder, M; Fuchs, S; Khalil, M; Fazekas, F; Enzinger, C
(2011): Cognitively preserved MS patients demonstrate functional differences in processing neutral and emotional faces J NEUROL. 2011; 258: 154-154.




2010

Originalarbeiten (Zeitschrift)

Mader, S; Lutterotti, A; Di Pauli, F; Kuenz, B; Schanda, K; Aboul-Enein, F; Khalil, M; Storch, MK; Jarius, S; Kristoferitsch, W; Berger, T; Reindl, M
(2010): Patterns of Antibody Binding to Aquaporin-4 Isoforms in Neuromyelitis Optica PLOS ONE. 2010; 5(5): e10455-e10455.
[Fulltext][PubMed]

Fazekas, C; Khalil, M; Enzinger, C; Fuchs, S; Fazekas, F
(2010): Attachment style and temperament in people with early stages of multiple sclerosis J PSYCHOSOM RES. 2010; 68(6): 47




2009

Originalarbeiten (Zeitschrift)

Khalil, M; Enzinger, C; Langkammer, C; Tscherner, M; Wallner-Blazek, M; Jehna, M; Ropele, S; Fuchs, S; Fazekas, F
(2009): Quantitative assessment of brain iron by R(2)* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis. Mult Scler. 2009; 15(9): 1048-1054.
[Fulltext][PubMed]

Khalil, M; Enzinger, C; Langkammer, C; Petrovic, K; Loitelder, M; Tscherner, M; Jehna, M; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F
(2009): The Spectrum of Cognitive Impairment and Its Relation to Brain Morphology Including Iron Deposition in Multiple Sclerosis. NEUROLOGY. 2009; 72(11):A142-A142.-61st Annual Meeting of the American Academy of Neurology (AAN); APR 25-May 2, 2009; Seattle, USA.


Khalil, M; Enzinger, C; Langkammer, C; Petrovic, K; Loitfelder, M; Tscherner, M; Jehna, M; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F
(2009): Cognitive impairment in patients with a clinically isolated syndrome - correlation with MRI parameters including magnetization transfer imaging. MULT SCLER. 2009; 15(9):S227-S228.-25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); SEP 9–12, 2009; Düsseldorf, GERMANY.


Khalil, M; Enzinger, C; Langkammer, C; Tscherner, M; Wallner-Blazek, M; Jehna, M; Ropele, S; Fuchs, S; Fazekas, F
(2009): Quantitative Assessment of Brain Iron by R2(star) Relaxometry in Patients with Clinically Isolated Syndrome or Relapsing Remitting Multiple Sclerosis. NEUROLOGY. 2009; 72(11):A435-A435.-61st Annual Meeting of the American Academy of Neurology (AAN); APR 25-May 2 2009; Seattle, USA.




2008

Originalarbeiten (Zeitschrift)

Khalil, M; Enzinger, C; Wallner-Blazek, M; Scarpatetti, M; Barth, A; Horn, S; Reiter, G
(2008): Epstein-Barr virus encephalitis presenting with a tumor-like lesion in an immunosuppressed transplant recipient. J Neurovirol. 2008; 14(6): 574-578.
[Fulltext][PubMed]

Khalil, M; Enzinger, C; Petrovic, K; Loitfelder, M; Tscherner, M; Jehna. M; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F
(2008): Executive dysfunction represents an underestimated component of cognitive impairment in multiple sclerosis. Multiple Sclerosis2008; 14(S1):S258-S259.-World Congress on Treatment and Research in Multiple Sclerosis: ACTRIMS + ECTRIMS + LACTRIMS; SEPT 17-20, 2008; Montreal, CANADA.




2006

Originalarbeiten (Zeitschrift)

Gneiss, C; Tripp, P; Ehling, R; Khalil, M; Lutterotti, A; Egg, R; Mayringer, I; Künz, B; Berger, T; Reindl, M; Deisenhammer, F
(2006): Interferon-beta antibodies have a higher affinity in patients with neutralizing antibodies compared to patients with non-neutralizing antibodies. J Neuroimmunol. 2006; 174(1-2): 174-179.
[Fulltext][PubMed]

Gneiss, C; Tripp, P; Reichartseder, F; Egg, R; Ehling, R; Lutterotti, A; Khalil, M; Kuenz, B; Mayringer, I; Reindl, M; Berger, T; Deisenhammer, F
(2006): Differing immunogenic potentials of interferon beta preparations in multiple sclerosis patients. Mult Scler. 2006; 12(6):731-737
[Fulltext][PubMed]

Khalil, M; Reindl, M; Lutterotti, A; Kuenz, B; Ehling, R; Gneiss, C; Lackner, P; Deisenhammer, F; Berger, T
(2006): Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatments. J Neuroimmunol. 2006; 174(1-2):147-156
[Fulltext][PubMed]

Lutterotti, A; Kuenz, B; Gredler, V; Khalil, M; Ehling, R; Gneiss, C; Egg, R; Deisenhammer, F; Berger, T; Reindl, M
(2006): Increased serum levels of soluble CD14 indicate stable multiple sclerosis. J Neuroimmunol. 2006; 181(1-2):145-149
[Fulltext][PubMed]

Reindl, M; Khalil, M; Berger, T
(2006): Antibodies as biological markers for pathophysiological processes in MS. J Neuroimmunol. 2006; 180(1-2):50-62
[Fulltext][PubMed]

Khalil, M; Kuenz, B; Lutterotti, A; Ehling, R; Gneiss, C; Egg, R; Mayringer, I; Deisenhammer, F; Reindl, M; Berger, T
(2006): Levels of serum IgM antibody against refolded recombinant human MOG predict responsiveness to corticosteroids for treatment of acute multiple sclerosis relapses J NEUROIMMUNOL. 2006; 178: 202-202.


Khalil, M; Zehrer, V; Egg, R; Lutterotti, A; Ehling, R; Gneiss, C; Mayringer, I; Kuenz, B; Reindl, M; Deisenhammer, F; Berger, T
(2006): Interferon-beta in multiple sclerosis: ten years' experience in a multiple sclerosis specialist centre MULT SCLER. 2006; 12: S195-S195.


Kuenz, B; Lutterotti, A; Ehling, R; Gneiss, C; Khalil, M; Deisenhammer, F; Berger, T; Reindl, M
(2006): Characterisation of cell populations in cerebrospinal fluid of patients with multiple sclerosis MULT SCLER. 2006; 12: S64-S64.


Lutterotti, A; Kuenz, B; Khalil, M; Gredler, V; Ehling, R; Gneiss, C; Deisenhammer, F; Berger, T; Reindl, M
(2006): Serum levels of soluble CD14 correlate with disease activity in multiple sclerosis patients and are increased by interferon-beta treatment MULT SCLER. 2006; 12: S66-S66.




2005

Originalarbeiten (Zeitschrift)

Kuenz, B; Lutterotti, A; Khalil, M; Ehling, R; Gneiss, C; Deisenhammer, F; Reindl, M; Berger, T
(2005): Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis. J Neuroimmunol. 2005; 167(1-2):143-149
[Fulltext][PubMed]

Gneiss, C; Brugger, M; Reindl, M; Berger, T; Ehling, R; Lutterotti, A; Khalil, M; Kunz, B; Mayringer, I; Deisenhammer, F
(2005): Comparative study of four different assays for the detection of binding antibodies against interferon-beta MULT SCLER. 2005; 11: S159-S160.


Khalil, M; Egg, R; Reindl, M; Lutterotti, A; Ehling, R; Gneiss, C; Kuenz, B; Deisenhammer, F; Berger, T
(2005): Influence of immunomodulatory therapies on anti-myelin-antibodies in multiple sclerosis (MS) J NEUROL SCI. 2005; 238: S225-S225.


Khalil, M; Reindl, M; Lutterotti, A; Ehling, R; Gneiss, C; Kunz, B; Deisenhammer, F; Berger, T
(2005): Impact of acute relapses and high-dose methylprednisolone therapy on serum anti-MOG antibodies in relapsing-remitting MS patients MULT SCLER. 2005; 11: S169-S169.


Kunz, B; Lutterotti, A; Ehling, R; Khalil, M; Reindl, M; Berger, T
(2005): Increased plasma levels of soluble adhesion molecules sE-selectin, sPECAM-1 and sP-selectin are associated with relapsing-remitting disease course of multiple sclerosis MULT SCLER. 2005; 11: S128-S128.




2004

Originalarbeiten (Zeitschrift)

Ehling, R; Lutterotti, A; Wanschitz, J; Khalil, M; Gneiss, C; Deisenhammer, F; Reindl, M; Berger, T
(2004): Increased frequencies of serum antibodies to neurofilament light in patients with primary chronic progressive multiple sclerosis. Mult Scler. 2004; 10(6):601-606
[Fulltext][PubMed]

Gneiss, C; Reindl, M; Lutterotti, A; Ehling, R; Egg, R; Khalil, M; Berger, T; Deisenhammer, F
(2004): Interferon-beta: the neutralizing antibody (NAb) titre predicts reversion to NAb negativity. Mult Scler. 2004; 10(5):507-510
[Fulltext][PubMed]

Khalil, M; Harrasser, M; Lutterotti, A; Ehling, R; Gneiss, C; Deisenhammer, F; Reindl, M; Berger, T
(2004): The ability of anti MOG antibodies to fix the terminal complement complex differs among multiple sclerosis patients with different disease courses MULT SCLER. 2004; 10(7032): S104-S104.


Khalil, M; Reindl, M; Egg, R; Lutterotti, A; Ehling, R; Gneiss, C; Deisenhammer, E; Berger, T
(2004): Influence of immunomodulatory therapies on anti-myelin antibodies in multiple sclerosis MULT SCLER. 2004; 10(7032):S211-S212.


Khalil, M; Reindl, M; Lutterotti, A; Ehling, R; Gneiss, C; Deisenhammer, F; Berger, T
(2004): Epitope specificity of antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein (MOG-1g) during immunomodulatory therapies in multiple sclerosis patients MULT SCLER. 2004; 10(7032): S165-S165.


Lutterotti, A; Ehling, R; Lassmann, H; Khalil, M; Gneiss, C; Gassner, C; Deisenhammer, F; Berger, T; Reindl, M
(2004): The CD14 C(-260)T promoter polymorphism influences disease severity in multiple sclerosis patients MULT SCLER. 2004; 10(7032): S208-S208.




  • TEXT
  • TEXT
  • TEXT
  • TEXT